Tirzepatide
Dual GIP/GLP-1 receptor agonist for body-composition research
Tirzepatide (LY3298176)
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It produces greater body weight reduction than single GLP-1 agonists by simultaneously activating multiple pathways of energy regulation.
A dual GIP and GLP-1 receptor agonist studied for multi-pathway energy regulation and insulin sensitivity.
For Research Use Only
Not for human consumption, veterinary use, or any therapeutic applications. Purchase requires valid research credentials.
Purity
Purity Exceeds 99%
Storage
2–8°C
Form
Lyophilized
Grade
Research
Tirzepatide Overview
A dual GIP and GLP-1 receptor agonist studied for multi-pathway energy regulation and insulin sensitivity.
Specifications
| Composition | Tirzepatide (LY3298176) |
|---|---|
| Molecular Formula | C225H348N48O68 |
| Half-Life | ~120 hours (≈5 days) |
| Purity | Purity Exceeds 99% |
| Available Sizes | 10mg, 30mg |
| Storage | 2–8°C, protect from light |
| SKU | TR10 |
| Grade | Research / Laboratory use only |



